3. WILLIAMS A R, HARE J M. Mesenchymal stem cells: biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease[J]. Circ Res, 2011, 109(8): 923-940.
[3]
4. KAGAMI H, AGATA H, TOJO A. Bone marrow stromal cells (bone marrow-derived multipotent mesenchymal stromal cells) for bone tissue engineering: basic science to clinical translation[J]. Int J Biochem Cell Biol, 2011, 43(3): 286-289.
[4]
5. BERNARDO M E, FIBBE W E. Safety and efficacy of mesenchymal stromal cell therapy in autoimmune disorders[J]. Ann N Y Acad Sci, 2012, 1266: 107-117.
[5]
8. IONESCU L, BYRNE R N, VAN HAAFTEN T, et al. Stem cell conditioned medium improves acute lung injury in mice: in vivo evidence for stem cell paracrine action[J]. Am J Physiol Lung Cell Mol Physiol, 2012, 303(11): L967-L977.
[6]
10. AMOS P J, MULVEY C L, SEAMAN S A, et al. Hypoxic culture and in vivo inflammatory environments affect the assumption of pericyte characteristics by human adipose and bone marrow progenitor cells[J]. Am J Physiol Cell Physiol, 2011, 301(6): C1378-C1388.
[7]
13. JUNG K H, SONG S U, YI T, et al. Human bone marrow-derived clonal mesenchymal stem cells inhibit inflammation and reduce acute pancreatitis in rats[J]. Gastroenterology, 2011, 140(3): 998-1008.
[8]
15. WU Qiaoyi, WANG Feng, HOU Yuling, et al. The effect of allogenetic bone marrow-derived mesenchymal stem cell transplantation on lung aquaporin-1 and-5 in a rat model of severe acute pancreatitis[J]. Hepatogastroenterology, 2012, 59(116): 965-976.
18. BONNER-WEIR S, INADA A, YATOH S, et al. Transdifferentiation of pancreatic ductal cells to endocrine beta-cells[J]. Biochem Soc Trans, 2008, 36(Pt 3): 353-356.
[11]
20. QIN Zhaohui, XU Jinfu, QU Jieming, et al. Intrapleural delivery of MSCs attenuates acute lung injury by paracrine/endocrine mechanism[J]. J Cell Mol Med, 2012, 16(11): 2745-2753.
[12]
22. ZHAO Manman, CUI Jianzhong, CUI Ying, et al. Therapeutic effect of exogenous bone marrow-derived mesenchymal stem cell transplantation on silicosis via paracrine mechanisms in rats[J]. Mol Med Rep, 2013, 8(3): 741-746.
[13]
26. REIS L A, BORGES F T, SIM？ES M J, et al. Bone marrow-derived mesenchymal stem cells repaired but did not prevent gentamicin-induced acute kidney injury through paracrine effects in rats[J]. PLoS One, 2012, 7(9): e44092.
[14]
29. WASZAK P, ALPHONSE R, VADIVEL A, et al. Preconditioning enhances the paracrine effect of mesenchymal stem cells in preventing oxygen-induced neonatal lung injury in rats[J]. Stem Cells Dev, 2012, 21(15): 2789-2797.
[15]
1. ？BURDON T J, PAUL A, NOISEUX N, et al. Bone marrow stem cell derived paracrine factors for regenerative medicine: current perspectives and therapeutic potential[J]. Bone Marrow Res, 2011, 2011: 207326.
7. AKRAM K M, SAMAD S, SPITERI M A, et al. Mesenchymal stem cells promote alveolar epithelial cell wound repair in vitro through distinct migratory and paracrine mechanisms[J]. Respir Res, 2013, 14(1): 9.
[18]
9. LEE J W, FANG Xiaohui, KRASNODEMBSKAYA A, et al. Concise review: Mesenchymal stem cells for acute lung injury: role of paracrine soluble factors[J]. Stem Cells, 2011, 29(6): 913-919.
[19]
11. ZENG Dongfeng, LIU Ting, CHANG Cheng, et al. Silencing HIF-1αreduces the adhesion and secretion functions of acute leukemia hBMSCs[J]. Braz J Med Biol Res, 2012, 45(10): 906-912.
[20]
12. KYL？NP？？ L, RAKONCZAY Z Jr, O'REILLY D A. The clinical course of acute pancreatitis and the inflammatory mediators that drive it[J]. Int J Inflam, 2012, 2012: 360685.
[21]
14. WANG Lie, TU Xiaohuang, ZHAO Peng, et al. Protective effect of transplanted bone marrow-derived mesenchymal stem cells on pancreatitis-associated lung injury in rats[J]. Mol Med Rep, 2012, 6(2): 287-292.
[22]
16. TU Xiaohuang, SONG Jingxiang, XUE Xiaojun, et al. Role of bone marrow-derived mesenchymal stem cells in a rat model of severe acute pancreatitis[J]. World J Gastroenterol, 2012, 18(18): 2270-2279.
[23]
19. DOR Y, BROWN J, MARTINEZ O I, et al. Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation[J]. Nature, 2004, 429(6987): 41-46.
[24]
21. YAGI H, SOTO-GUTIERREZ A, NAVARRO-ALVAREZ N, et al. Reactive bone marrow stromal cells attenuate systemic inflammation via sTNFR1[J]. Mol Ther, 2010, 18(10): 1857-1864.
24. YI T, SONG S U. Immunomodulatory properties of mesenchymal stem cells and their therapeutic applications[J]. Arch Pharm Res, 2012, 35(2): 213-221.
[27]
25. XU Xiang, ZHU Fangqiang, ZHANG Meng, et al. Stromal cell-derived factor-1 enhances wound healing through recruiting bone marrow-derived mesenchymal stem cells to the wound area and promoting neovascularization[J]. Cells Tissues Organs, 2013, 197(2): 103-113.
[28]
27. LIU Nanmei, PATZAK A, ZHANG Jinyuan. CXCR4-overexpressing bone marrow-derived mesenchymal stem cells improve repair of acute kidney injury[J]. Am J Physiol Renal Physiol, 2013, 305(7): F1064-F1073.
[29]
28. BINATO R, DE SOUZA FERNANDEZ T, LAZZAROTTO-SILVA C, et al. Stability of human mesenchymal stem cells during in vitro culture: considerations for cell therapy[J]. Cell Prolif, 2013, 46(1): 10-22.
[30]
30. LI M, TILLES A W, MILWID J M, et al. Phenotypic and functional characterization of human bone marrow stromal cells in hollow-fibre bioreactors[J]. J Tissue Eng Regen Med, 2012, 6(5): 369-377.
